Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Operable Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT04610528
What this trial is testing

A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 80
Not applicableUnknownNCT01592825
What this trial is testing

PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors

Who this might be right for
Breast Cancer
Martin-Luther-Universität Halle-Wittenberg 1,000
Testing effectiveness (Phase 2)Study completedNCT00405678
What this trial is testing

Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.

Who this might be right for
Breast Cancer
Duke University 23
Testing effectiveness (Phase 2)WithdrawnNCT02215876
What this trial is testing

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT01745965
What this trial is testing

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.

Who this might be right for
Breast Cancer
Women's Cancer Study Group GmbH 380
Not applicableUnknownNCT02012634
What this trial is testing

Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer

Who this might be right for
Breast CancerCapecitabineTriple Negative Breast Cancer
Xijing Hospital 340
Not applicableUnknownNCT03900299
What this trial is testing

Evaluating New Surgical Technique in Management of Female Patients With Operable Multifocal Breast Cancer

Who this might be right for
Breast Cancer
Alexandria University 114
Not applicableUnknownNCT00538330
What this trial is testing

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
King Faisal Specialist Hospital & Research Center 2,000
Testing effectiveness (Phase 2)WithdrawnNCT00434031
What this trial is testing

CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute, Naples
Large-scale testing (Phase 3)Study completedNCT00017095
What this trial is testing

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,856
Large-scale testing (Phase 3)Active Not RecruitingNCT02221999
What this trial is testing

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 250
Testing effectiveness (Phase 2)Study completedNCT02008734
What this trial is testing

Randomized Phase II Study to Assess PD 0332991 in Breast Cancer

Who this might be right for
Untreated Operable Early Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 132
Not applicableUnknownNCT03842176
What this trial is testing

Clinical Application of CTC in Operable Breast Cancer Patients

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00424203
What this trial is testing

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCognitive/Functional EffectsDepression+2 more
UNICANCER 40
Testing effectiveness (Phase 2)Study completedNCT00559754
What this trial is testing

Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 72
Very early researchEnded earlyNCT00651976
What this trial is testing

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 213
Testing effectiveness (Phase 2)Study completedNCT00203502
What this trial is testing

Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Arkansas 40
Not applicableLooking for participantsNCT06762977
What this trial is testing

A Composite Assay for HER2-positive Early-stage Breast Cancer Management

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)HER2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 180
Large-scale testing (Phase 3)Study completedNCT00232661
What this trial is testing

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

Who this might be right for
Breast Cancer
AstraZeneca 452
Large-scale testing (Phase 3)UnknownNCT01647672
What this trial is testing

Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University 60
Next Page